PASITHEA THERAPEUTICS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PASITHEA THERAPEUTICS CORP. (KTTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 5.87 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-12-31 was 400.00K shares.
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 0.00 shares.
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 800.00K shares, a 33.33% increase from fiscal 2021.
- PASITHEA THERAPEUTICS CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 600.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 5.87M shares 10-Q · filed 2026-08-14 | ||||
| 2024-09-30 | 104.43K shares 10-Q · filed 2024-11-13 | ||||
| 2022-12-31 | 400.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 400.00K shares derived: sum of 2 quarters · filed 2023-03-30 | 800.00K shares 10-K · filed 2023-03-30 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 400.00K shares 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 400.00K shares 10-Q · filed 2022-08-15 | ||||
| 2021-12-31 | 600.00K shares 10-K · filed 2023-03-30 | 400.00K shares 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |